Impact of Early Administration of Albumin on Mortality Among Severe COVID-19 Patients, China
Hypoalbuminemia was correlated with adverse outcomes in severe COVID-19 patients. However, early albumin administration did not reduce 28-day mortality and in-hospital mortality in these patients, and more relative RCTs were required for validation.
Authors
- Guiqing Kong
- Lin Fu (ORCID: https://orcid.org/0000-0003-1069-3560)
- Fangqiang Song
- Yufeng Chu (ORCID: https://orcid.org/0000-0002-9160-7021)
- Jing Sha
- Lin Zhang (ORCID: https://orcid.org/0000-0002-3767-0249)
- Peng Wang (ORCID: https://orcid.org/0000-0003-4303-6081)
- Tao Wang (ORCID: https://orcid.org/0000-0001-9372-1648)
- Mei Meng (ORCID: https://orcid.org/0000-0001-5775-4557)
Institutions
- Shandong University of Aeronautics (CN)
- Shanghai Ninth People's Hospital (CN)
- Second Hospital of Shandong University (CN)
- Shandong Provincial Hospital (CN)
- Binzhou People's Hospital (CN)
- Tengzhou Central People's Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/idr.s510245
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Natural Science Foundation of Shandong Province